{"title":"从小处着手:利用精确有限样本可能性在随机实验中优先考虑安全性而非有效性","authors":"Neil Christy, A. E. Kowalski","doi":"arxiv-2407.18206","DOIUrl":null,"url":null,"abstract":"We use the exact finite sample likelihood and statistical decision theory to\nanswer questions of ``why?'' and ``what should you have done?'' using data from\nrandomized experiments and a utility function that prioritizes safety over\nefficacy. We propose a finite sample Bayesian decision rule and a finite sample\nmaximum likelihood decision rule. We show that in finite samples from 2 to 50,\nit is possible for these rules to achieve better performance according to\nestablished maximin and maximum regret criteria than a rule based on the\nBoole-Frechet-Hoeffding bounds. We also propose a finite sample maximum\nlikelihood criterion. We apply our rules and criterion to an actual clinical\ntrial that yielded a promising estimate of efficacy, and our results point to\nsafety as a reason for why results were mixed in subsequent trials.","PeriodicalId":501293,"journal":{"name":"arXiv - ECON - Econometrics","volume":"61 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Starting Small: Prioritizing Safety over Efficacy in Randomized Experiments Using the Exact Finite Sample Likelihood\",\"authors\":\"Neil Christy, A. E. Kowalski\",\"doi\":\"arxiv-2407.18206\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We use the exact finite sample likelihood and statistical decision theory to\\nanswer questions of ``why?'' and ``what should you have done?'' using data from\\nrandomized experiments and a utility function that prioritizes safety over\\nefficacy. We propose a finite sample Bayesian decision rule and a finite sample\\nmaximum likelihood decision rule. We show that in finite samples from 2 to 50,\\nit is possible for these rules to achieve better performance according to\\nestablished maximin and maximum regret criteria than a rule based on the\\nBoole-Frechet-Hoeffding bounds. We also propose a finite sample maximum\\nlikelihood criterion. We apply our rules and criterion to an actual clinical\\ntrial that yielded a promising estimate of efficacy, and our results point to\\nsafety as a reason for why results were mixed in subsequent trials.\",\"PeriodicalId\":501293,\"journal\":{\"name\":\"arXiv - ECON - Econometrics\",\"volume\":\"61 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"arXiv - ECON - Econometrics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/arxiv-2407.18206\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"arXiv - ECON - Econometrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/arxiv-2407.18206","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Starting Small: Prioritizing Safety over Efficacy in Randomized Experiments Using the Exact Finite Sample Likelihood
We use the exact finite sample likelihood and statistical decision theory to
answer questions of ``why?'' and ``what should you have done?'' using data from
randomized experiments and a utility function that prioritizes safety over
efficacy. We propose a finite sample Bayesian decision rule and a finite sample
maximum likelihood decision rule. We show that in finite samples from 2 to 50,
it is possible for these rules to achieve better performance according to
established maximin and maximum regret criteria than a rule based on the
Boole-Frechet-Hoeffding bounds. We also propose a finite sample maximum
likelihood criterion. We apply our rules and criterion to an actual clinical
trial that yielded a promising estimate of efficacy, and our results point to
safety as a reason for why results were mixed in subsequent trials.